Patient Characteristics and Healthcare Resource Use among Patients With COVID-19 Receiving Treatment with Nirmatrelvir/Ritonavir (PAXLOVID™) in the Kingdom of Saudi Arabia.
Saved in:
| Title: | Patient Characteristics and Healthcare Resource Use among Patients With COVID-19 Receiving Treatment with Nirmatrelvir/Ritonavir (PAXLOVID™) in the Kingdom of Saudi Arabia. |
|---|---|
| Authors: | Alraddadi, Basem M.1 (AUTHOR), Almaghrabi, Reem S.2 (AUTHOR), Bosaeed, Mohammad3,4,5 (AUTHOR), Kamal, Mohamed6 (AUTHOR), Hassanien, Ashraf7 (AUTHOR), Hammam, Haridy8 (AUTHOR), Zanotti, Giovanni9 (AUTHOR), Ikizler, Burcu Karakuzu10 (AUTHOR), d'Hellencourt, Florence Lefebvre9 (AUTHOR), Spinardi, Julia Regazzini11 (AUTHOR), Wang, Lu9 (AUTHOR), Kyaw, Moe H.9 (AUTHOR) Moe.Kyaw@pfizer.com |
| Source: | Pulmonary Therapy. Jun2026, Vol. 12 Issue 2, p617-635. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23641746 |
|---|---|
| DOI: | 10.1007/s41030-026-00360-3 |
